Eton Pharmaceuticals, Inc. (ETON) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$29,315
Total Return
193.15%
CAGR
24.00%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.69% |
| Median | +0.36% |
| Best | +99.62% |
| Worst | -44.16% |
| % of Windows Positive | 50.6% |
1-Year (252 Trading Days)
| Average | +74.56% |
| Median | +24.38% |
| Best | +459.12% |
| Worst | -63.34% |
| % of Windows Positive | 65.8% |
3-Year (756 Trading Days)
| Average | +301.71% |
| Median | +330.14% |
| Best | +970.48% |
| Worst | -60.15% |
| % of Windows Positive | 80.8% |
Risk Metrics
| Maximum Drawdown | -77.18% |
| Average Drawdown | -42.54% |
| Drawdown Duration | 872 Trading Days |
| Sortino Ratio | 1.01 |
| Calmar Ratio | 0.31 |
| CVaR (5%) | -8.55% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +39.21% (+196.98% ann.) | +$3920.76 | $0.00 | $0.00 | $0.00 |
| 2025 | +26.95% | +$2695.20 | $0.00 | $0.00 | $0.00 |
| 2024 | +204.11% | +$20410.96 | $0.00 | $0.00 | $0.00 |
| 2023 | +55.32% | +$5531.91 | $0.00 | $0.00 | $0.00 |
| 2022 | -34.27% | $3426.57 | $0.00 | $0.00 | $0.00 |
| 2021 | -47.23% | $4723.25 | $0.00 | $0.00 | $0.00 |
| 2020 | +12.92% | +$1291.67 | $0.00 | $0.00 | $0.00 |
| 2019 | +17.65% | +$1764.71 | $0.00 | $0.00 | $0.00 |
| 2018 partial | -2.08% (-14.78% ann.) | $208.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | November 13, 2018 – February 19, 2020 | +8.80% | +6.88% | +$880.00 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -54.00% | -99.99% | $5400.00 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +110.61% | +231.49% | +$11060.61 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -39.82% | -38.23% | $3982.04 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -34.87% | -36.57% | $3487.18 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +127.89% | +55.95% | +$12788.84 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +298.31% | +138.77% | +$29830.80 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.